Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1997-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.82.3.3808PMID 9062507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exercise-induced hypoglycaemia in IDDM patients treated with a short-acting insulin analogue

  2006cited by this paper
• Meal Composition is a Determinant of Lispro-Induced Hypoglycemia in IDDM

  1997cited by this paper
• Validity of Coat-A-Count insulin RIA kit for quantifying total and free humalog.

  1996cited by this paper
• Pre‐meal Insulin Analogue Insulin Lispro vs Humulin® R Insulin Treatment in Young Subjects with Type 1 Diabetes

  1996cited by this paper
• Humalog, a rapidly absorbed analog of human insulin, determined with Coat-A-Count insulin radioimmunoassay.

  1995cited by this paper
• [Lys(B28), Pro(B29)]‐human insulin: Effect of injection time on postprandial glycemia

  1995cited by this paper
• Improved Postprandial Metabolic Control After Subcutaneous Injection of a Short-Acting Insulin Analog in IDDM of Short Duration With Residual Pancreatic β-Cell Function

  1995cited by this paper
• Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

  1994cited by this paper
• Effect of the insulin analogue [LYS(B28),PRO(B29)] on blood glucose control.

  1994cited by this paper
• [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin

  1994cited by this paper
• Effect of the Insulin Analogue [LYS(B28),PRO(B29)] on Blood Glucose Control

  1994cited by this paper
• Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Intensive Insulin Therapy for Treatment of Type I Diabetes

  1990cited by this paper
• Assessment of the postprandial pattern of glucose metabolism in nondiabetic subjects and patients with non-insulin-dependent diabetes mellitus using a simultaneous infusion of [2(3)H] and [3(3)H] glucose.

  1989cited by this paper
• The Importance of the Time Interval Between Insulin Injection and Breakfast in Determining Postprandial Glycaemic Control—A Comparison Between Human and Porcine Insulin

  1988cited by this paper
• External and internal standards in the single-isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine.

  1985cited by this paper
• Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes Mellitus

  1983cited by this paper
• Insulin delivery with meals. Plasma insulin profiles after bolus injection of human or porcine neutral insulin.

  1983cited by this paper
• Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance.

  1973cited by this paper

• Recent advances in the determination of insulins from biological fluids.

  2019cites this paper
• Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism.

  2015cites this paper
• Postprandial glycaemia: a plea for the frequent use of delta postprandial glycaemia in the treatment of diabetic patients.

  2006cites this paper
• Comparison of Costs and Utilization Between Users of Insulin Lispro Versus Users of Regular Insulin in a Managed Care Setting

  2005cites this paper
• Comparison between continuous subcutaneous insulin infusion and multiple insulin injection therapy in type 1 diabetes mellitus: 18-month follow-up.

  2002cites this paper
• Intensive diabetes management in pediatric patients

  2001cites this paper
• Diabetes Mellitus and Closed-Loop Insulin Delivery

  2000cites this paper
• Tratamiento con insulina Lispro (Lys B28, Pro B29) en adolescentes y jóvenes con diabetes mellitus tipo 1

  2000cites this paper
• The use of fixed-mixture insulins in clinical practice

  2000cites this paper
• Type 1 diabetes mellitus and the use of flexible insulin regimens.

  1999cites this paper
• Insulin analogs with improved pharmacokinetic profiles.

  1999cites this paper
• Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen.

  1999cites this paper
• Effectiveness of human ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen. A double-blind randomized prospective trial. The Canadian Lispro Study Group.

  1999cites this paper
• Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

  1999cites this paper
• Insulin lispro (Humalog), a novel fast-acting insulin analogue for the treatment of diabetes mellitus: overview of pharmacological and clinical data.

  1999cites this paper
• Individualized insulin therapy in children and adolescents with type 1 diabetes

  1998cites this paper
• Meta-Analysis of the Effect of Insulin Lispro on Severe Hypoglycemia in Patients With Type 1 Diabetes

  1998cites this paper
• Intensive treatment of type 1 diabetes.

  1998cites this paper
• Lispro insulin: benefits and limitations.

  1998cites this paper
• Dietary therapy in type 2 diabetes oriented towards postprandial blood glucose improvement.

  1998cites this paper
• Guidelines for using insulin lispro.

  1998cites this paper
• Optimization of Evening Insulin Dose in Patients Using the Short-Acting Insulin Analog Lispro

  1998cites this paper
• Optimal Provision of Daytime NPH Insulin in Patients Using the Insulin Analog Lispro

  1998cites this paper
• Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.

  1997cites this paper
• Lispro insulin as premeal therapy in type 1 diabetes: comparison with Humulin R.

  1997cites this paper